Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Genelux (GNLX) Shares Outstanding (Weighted Average) (2022 - 2025)

Genelux has reported Shares Outstanding (Weighted Average) over the past 4 years, most recently at $37.2 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $37.2 million for Q4 2025, up 18.21% from a year ago — trailing twelve months through Dec 2025 was $37.2 million (up 18.21% YoY), and the annual figure for FY2025 was $37.2 million, up 18.21%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $37.2 million at Genelux, down from $37.9 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for GNLX hit a ceiling of $37.9 million in Q2 2025 and a floor of $3120.0 in Q3 2023.
  • Median Shares Outstanding (Weighted Average) over the past 4 years was $28.3 million (2024), compared with a mean of $24.7 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): plummeted 99.97% in 2023 and later soared 1106706.25% in 2024.
  • Genelux's Shares Outstanding (Weighted Average) stood at $9.1 million in 2022, then skyrocketed by 244.99% to $31.5 million in 2023, then changed by 0.0% to $31.5 million in 2024, then grew by 18.21% to $37.2 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $37.2 million (Q4 2025), $37.9 million (Q3 2025), and $37.9 million (Q2 2025) per Business Quant data.